These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 16501252)
1. Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer. Ai L; Tao Q; Zhong S; Fields CR; Kim WJ; Lee MW; Cui Y; Brown KD; Robertson KD Carcinogenesis; 2006 Jul; 27(7):1341-8. PubMed ID: 16501252 [TBL] [Abstract][Full Text] [Related]
2. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers. Taniguchi H; Yamamoto H; Hirata T; Miyamoto N; Oki M; Nosho K; Adachi Y; Endo T; Imai K; Shinomura Y Oncogene; 2005 Nov; 24(53):7946-52. PubMed ID: 16007117 [TBL] [Abstract][Full Text] [Related]
3. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo. Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305 [TBL] [Abstract][Full Text] [Related]
4. Adiponectin stimulates Wnt inhibitory factor-1 expression through epigenetic regulations involving the transcription factor specificity protein 1. Liu J; Lam JB; Chow KH; Xu A; Lam KS; Moon RT; Wang Y Carcinogenesis; 2008 Nov; 29(11):2195-202. PubMed ID: 18701434 [TBL] [Abstract][Full Text] [Related]
5. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours. Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564 [TBL] [Abstract][Full Text] [Related]
6. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma. Sathyanarayana UG; Padar A; Huang CX; Suzuki M; Shigematsu H; Bekele BN; Gazdar AF Clin Cancer Res; 2003 Dec; 9(17):6389-94. PubMed ID: 14695139 [TBL] [Abstract][Full Text] [Related]
7. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer. Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122 [TBL] [Abstract][Full Text] [Related]
8. Dysregulation of Wnt pathway components in human salivary gland tumors. Queimado L; Obeso D; Hatfield MD; Yang Y; Thompson DM; Reis AM Arch Otolaryngol Head Neck Surg; 2008 Jan; 134(1):94-101. PubMed ID: 18209144 [TBL] [Abstract][Full Text] [Related]
9. [Epigenetic inactivation of the WNT antagonist SFRP1 in breast cancer]. Dahl E; Veeck J; An H; Wiesmann F; Klopocki E; Sauter G; Kristiansen G; Hartmann A; Knüchel R Verh Dtsch Ges Pathol; 2005; 89():169-77. PubMed ID: 18035687 [TBL] [Abstract][Full Text] [Related]
10. TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers. Conway KE; McConnell BB; Bowring CE; Donald CD; Warren ST; Vertino PM Cancer Res; 2000 Nov; 60(22):6236-42. PubMed ID: 11103776 [TBL] [Abstract][Full Text] [Related]
11. Epigenetic silencing of the tumor suppressor cystatin M occurs during breast cancer progression. Ai L; Kim WJ; Kim TY; Fields CR; Massoll NA; Robertson KD; Brown KD Cancer Res; 2006 Aug; 66(16):7899-909. PubMed ID: 16912163 [TBL] [Abstract][Full Text] [Related]
12. SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers. Dallol A; Da Silva NF; Viacava P; Minna JD; Bieche I; Maher ER; Latif F Cancer Res; 2002 Oct; 62(20):5874-80. PubMed ID: 12384551 [TBL] [Abstract][Full Text] [Related]
13. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer. Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230 [TBL] [Abstract][Full Text] [Related]
14. WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer. Wissmann C; Wild PJ; Kaiser S; Roepcke S; Stoehr R; Woenckhaus M; Kristiansen G; Hsieh JC; Hofstaedter F; Hartmann A; Knuechel R; Rosenthal A; Pilarsky C J Pathol; 2003 Oct; 201(2):204-12. PubMed ID: 14517837 [TBL] [Abstract][Full Text] [Related]
15. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma. Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730 [TBL] [Abstract][Full Text] [Related]
16. Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma. Hu J; Dong A; Fernandez-Ruiz V; Shan J; Kawa M; Martínez-Ansó E; Prieto J; Qian C Cancer Res; 2009 Sep; 69(17):6951-9. PubMed ID: 19690140 [TBL] [Abstract][Full Text] [Related]
17. WIF1, an inhibitor of the Wnt pathway, is rearranged in salivary gland tumors. Queimado L; Lopes CS; Reis AM Genes Chromosomes Cancer; 2007 Mar; 46(3):215-25. PubMed ID: 17171686 [TBL] [Abstract][Full Text] [Related]
18. Epigenetic inactivation of the secreted frizzled-related protein-5 (SFRP5) gene in human breast cancer is associated with unfavorable prognosis. Veeck J; Geisler C; Noetzel E; Alkaya S; Hartmann A; Knüchel R; Dahl E Carcinogenesis; 2008 May; 29(5):991-8. PubMed ID: 18356147 [TBL] [Abstract][Full Text] [Related]
19. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma. Lee MG; Kim HY; Byun DS; Lee SJ; Lee CH; Kim JI; Chang SG; Chi SG Cancer Res; 2001 Sep; 61(18):6688-92. PubMed ID: 11559536 [TBL] [Abstract][Full Text] [Related]
20. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer. Taniguchi H; Yamamoto H; Akutsu N; Nosho K; Adachi Y; Imai K; Shinomura Y J Pathol; 2007 Oct; 213(2):131-9. PubMed ID: 17724792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]